Q2 FY2026 · ended Jun 30, 2026 · Revenue $9.74M, -3.1% YoY · Filed Aug 6, 2026
SANUWAVE Health, Inc. (SNWV) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $9.7 million and a net loss of $682,000. Free cash flow was $91,000. As of Jun 30, 2026 it held $9.4 million in cash and investments and $1.5 million in total debt.
Revenue
$9.74M
-3.1% vs year-ago quarter
Net income
$-682,000
-223.8% vs year-ago quarter
Operating cash flow
$425,000
-57.2% vs year-ago quarter
Free cash flow
$91,000
+154.8% vs year-ago quarter
EPS
$-0.08
-100.0% vs year-ago quarter
Dividend per share
None
Shares outstanding
8.60M
+0.4% vs year-ago quarter
Net cash
$7.85M
Q2 FY2026
Operating margin
3.4%
TTM
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- SNWV (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Eden Prairie, MN
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1417663
- Former names
- RUB MUSIC ENTERPRISES, INC. (until Feb 1, 2010)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $9.7M | $9.6M | $13.4M | $11.3M | $10.1M |
| Operating income | -$280,000 | -$1.1M | $2.0M | $903,000 | $1.4M |
| Net income | -$682,000 | -$1.4M | $7.7M | $9.7M | $551,000 |
| Diluted EPS | -$0.08 | -$0.17 | $0.87 | $0.39 | -$0.04 |
| Operating cash flow | $425,000 | $397,000 | $3.3M | $1.1M | $993,000 |
| Free cash flow | $91,000 | $374,000 | $3.2M | $556,000 | -$166,000 |
| Total assets | $36.6M | $37.1M | $37.3M | $35.6M | $33.0M |
| Total liabilities | $33.8M | $35.3M | $35.7M | $43.2M | $51.8M |
| Stockholders' equity | $2.8M | $1.8M | $1.6M | -$7.6M | -$18.8M |
| Cash and investments | $9.4M | $10.8M | $12.0M | $9.6M | $8.5M |
| Total debt | $1.5M | $22.1M | $22.9M | $24.4M | $1.2M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement
|
Oct 28, 2026 | Oct 28, 2026 |
| 8-K |
Current report
Listing notice
|
Sep 25, 2026 | Sep 23, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 13, 2026 | Jul 13, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 16, 2026 | Jun 16, 2026 |
All 751 SANUWAVE Health, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.